Australia markets open in 8 hours 28 minutes

SAVA Jan 2024 140.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.15000.0000 (0.00%)
As of 10:55AM EDT. Market open.
Full screen
Previous close0.1500
Open0.2900
Bid0.0000
Ask0.7500
Strike140.00
Expiry date2024-01-19
Day's range0.1500 - 0.2900
Contract rangeN/A
Volume5
Open interest656
  • GlobeNewswire

    Cassava Sciences Announces Positive Interim Safety Review of Simufilam On-going Phase 3 Trials in Patients with Alzheimer’s Disease

    An Independent Data and Safety Monitoring Board (DSMB) Recently Evaluated the Interim Patient Safety Database for Simufilam in On-Going Phase 3 Clinical Trials.The DSMB Recommended the Phase 3 Trials of Simufilam Continue as Planned, Without Modification AUSTIN, Texas, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer’s disease, today announced a positive interim safety review of simufilam in on-going Phase 3 clinical trials in

  • GlobeNewswire

    Cassava Sciences Announces Science Publication That Confirms Mechanism of Action of Simufilam, a Novel Drug Candidate for People with Alzheimer’s Disease

    New cell biology data from Europe shows simufilam interrupts a pathogenic signaling pathway in Alzheimer’s disease.Results corroborate prior research from other academic researchers.These data once again confirm the biological activity of simufilam. AUSTIN, Texas, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer’s disease, today announced the publication of new research that confirms the biological activity of simufilam. Simuf

  • GlobeNewswire

    Cassava Sciences Invited to Present in Four Upcoming Investor Conferences

    AUSTIN, Texas, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company committed to the treatment of Alzheimer’s disease dementia, today announced that it has been invited to present at the following investor conferences. Event:Morgan Stanley - 21stAnnual Global Healthcare ConferenceFormat:Fireside chat with Remi Barbier, President & CEODate:Monday, September 11, 2023Where:New York City Event:H.C. Wainwright - 25thAnnual Global Investment ConferenceForma